When compared with PET/CT with other PSMA-targeted tracers (18F-DCFPyL and 68Ga-PSMA), 18F-PSMA-1007 PET/CT showed similar results in terms of diagnostic accuracy for PCa staging with an almost perfect concordance in PCa lesion detection among the different PSMA-targeted tracers, but with an overall higher uptake in PCa lesions (measured as SUVmax) compared with other PSMA-targeted agents [26,29]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.